The use of insulin was accompanied by a retinal picture similar to that of the control group, while the combined use of sorafenib and insulin prevented the development of both morphological signs of diabetic retinopathy (DR) and an increase in the intensity of VEGF-positive staining (see Figures 3C, D). Here, INS is linked to diabetic retinopathy.